Results 211 to 220 of about 205,631 (301)

3D‐printed model for resection of positive surgical margins in robot‐assisted prostatectomy

BJU International, Volume 135, Issue 4, Page 657-667, April 2025.
Objectives To improve precision of secondary resection (SR) after positive surgical margin (PSM) detection by frozen section (FS) during nerve‐sparing (NS) robot‐assisted radical prostatectomy (RARP) by employing a personalised three‐dimensional (3D)‐printed prostate model derived from pelvic magnetic resonance imaging (MRI).
Christian Engesser, Philipp Brantner, Brigitta Gahl, Matthias Walter, Julian Gehweiler, Helge Seifert, Svetozar Subotic, Cyrill Rentsch, Christian Wetterauer, Lukas Bubendorf, Tatjana Vlajnic, Abolfazl Hosseini, Jan Ebbing   +12 more
wiley   +1 more source

Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical Trial.

JAMA Oncol
Belliveau C, Saad F, Duplan D, Petit C, Delouya G, Taussky D, Barkati M, Lambert C, Beauchemin MC, Clavel S, Mok G, Igidbashian L, Gauthier-Paré AS, Nguyen TV, McLaughlin PY, Keu KV, DaSilva JN, Juneau D, Ménard C.   +18 more
europepmc   +1 more source

External Validation of Nomograms for Predicting Pelvic Lymph Node Metastases in Patients with Prostate Cancer and the Added Value of the Prostate-specific Membrane Antigen Positron Emission Tomography-based PRIMARY Score. [PDF]

Eur Urol Open Sci
Demirbilek M, Kalender G, Bıyıkoglu S, Asa S, Akkuş E, Gürses İ, Kabasakal L, Önal B.   +7 more
europepmc   +1 more source

The Role of Prostate-Specific Membrane Antigen (PSMA) PET-CT in Characterizing Suspected Synchronous Rectal Lesions in a Case of High-Grade Prostatic Adenocarcinoma. [PDF]

Cureus
Sankar G, Tarafdar S, Halder A, Saha R, Tummidi S.   +4 more
europepmc   +1 more source

The LaserSAFE technique for margin assessment during radical prostatectomy: a feasibility study

BJU International, EarlyView.
Objectives To assess the feasibility of conducting a multicentre trial comparing NeuroSAFE with a novel technique based on confocal laser microscopy (LaserSAFE) and evaluate the diagnostic performance of LaserSAFE for real‐time surgical margin assessment.
Ricardo Almeida‐Magana, Larissa Sena Teixeira Mendes, Eoin Dinneen, Tarek Al‐Hammouri, Aiman Haider, Anna Silvanto, Alex Freeman, Nicholas Roberts, Louise Dickinson, Chun Wah So, Zafer Tandogdu, Benjamin W. Lamb, Nikhil Mayor, Mathias Winkler, Hashim Ahmed, Greg Shaw   +15 more
wiley   +1 more source

Reduction of Negative Charge in Mercaptoacetyl-Based Chelators Influences the Biodistribution of Prostate-Specific Membrane Antigen-Targeting Pseudopeptides Labeled with Technetium-99m. [PDF]

ACS Pharmacol Transl Sci
Bezverkhniaia E, Kanellopoulos P, Rosenström U, Tolmachev V, Orlova A.   +4 more
europepmc   +1 more source

Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy

BJU International, EarlyView.
Objectives To evaluate the impact of the presence, extent and location of positive surgical margins (PSMs) on the risk of biochemical recurrence (BCR) and metastases in a nationwide cohort of patients who underwent radical prostatectomy (RP) and had 5 years of follow‐up.
Joost van Drumpt, Diederik Baas, Katja Aben, Arno van Leenders, Lambertus Kiemeney, Michiel Sedelaar, Peter Mulders, Jean‐Paul van Basten, Inge van Oort, Berdine Heesterman, Diederik Somford   +10 more
wiley   +1 more source

Design and characterization of a novel prostate-specific membrane antigen-targeted radioligand modified with a fatty acid albumin binder for optimized circulation half-life. [PDF]

EJNMMI Radiopharm Chem
Zeng S, Gao X, Meng J, Yang X, Chi Z, Zhang Y, Zhou P, Li M, Zhang Y, Zhang X, Tang Y, Su Z, Tang J.   +12 more
europepmc   +1 more source

Focal therapy using a novel cooled laser device for prostate cancer: early trial results

BJU International, EarlyView.
Objectives To determine the short‐term oncological results and safety of the ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT‐PC) trial, the first phase II clinical trial of ProFocal® (Medlogical Innovations, Sydney, Australia), a novel, cooled laser focal therapy (cLFT) device for prostate cancer (PCa) treatment. Patients and Methods Men with
Jonathan Kam, Bishoy Hanna, Stuart Jackson, Stephen McCombie, George McClintock, Matthew J. Roberts, Jake Rahkala, Jeremy Teoh, Mohan Arianayagam, Bertram Canagasingham, Ahmed Saeed Goolam, Nicola Jeffery, Matthew Winter, Mohamed Khadra, Raymond Ko, Nicholas Mehan, Isaac Thangasamy, Celi Varol   +17 more
wiley   +1 more source